Racura Oncology Ltd

NEW
FRA:FN3 (Australia)  
€ 1.33 +0.010 (+0.76%) Jul 6
At Loss
P/B:
17.75
Market Cap:
€ 274.15M ($ 313.45M)
Enterprise V:
€ 261.47M ($ 298.96M)
Volume:
0
Avg Vol (2M):
1.41K
Trade In:
Volume:
0
At Loss
Avg Vol (2M):
1.41K

Racura Oncology Ltd (FRA:FN3) Dividend

Racura Oncology Ltd (FRA:FN3) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -2.9%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: FRA:FN3 Dividend

Does Racura Oncology Ltd (FRA:FN3) pay a dividend?

Racura Oncology Ltd (FRA:FN3) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Racura Oncology Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Racura Oncology Ltd has returned capital to shareholders via buybacks at a rate of -2.9% over the past 3 years.

What are dividend-paying alternatives to Racura Oncology Ltd?

For dividend-paying alternatives in Racura Oncology Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.